Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Beijing, Beijing Municipality
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Clinical Trials in Beijing, Beijing Municipality
1 recruiting
Beijing, Beijing Municipality, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Daihong Liu
30 enrolled
1 location
NCT07489989
Feedback